Scottish regulator approves first chronic hepatitis delta virus drug
Drug Discovery World
MARCH 17, 2023
The Scottish Medicines Consortium (SMC) has become the first UK health authority to permit routine NHS use of Gilead Sciences’ Hepcludex (bulevirtide) for the treatment of chronic hepatitis delta virus (HDV) infection. HDV infection is rare, but the effects of chronic HDV infection are potentially extremely serious.
Let's personalize your content